Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• Cardio-oncology explosion: Increasing awareness, collaboration, research Darlene Dobkowski, MA
• Clinical review of COVID-19 and CVD: What the cardiovascular practitioner needs to know Roger S. Blumenthal, MD
• FDA draft guidance eliminates CV outcomes trial recommendation for diabetes drug approvals Regina Schaffer
• AHA: Lifestyle modification key to management of AF
• CVD, not drug overdoses, may explain stagnation in US life expectancy
• Habitual fish oil supplementation lowers risk for mortality, CV events Carol Heunisch, PharmD, BCPS, BCCP
• In acute MI, care of homeless differs from general population Darlene Dobkowski, MA
• Recombinant C1 esterase inhibitor before coronary angiography may reduce renal injury
• EXTEND-IA TNK: Increased tenecteplase dose does not improve stroke outcomes
• Genotype-guided antiplatelet therapy strategy shows benefit after PCI Erik Swain
• High olive oil consumption lowers risk for heart disease
• Low-dose rivaroxaban reduces risk in PAD post-revascularization Katie Kalvaitis
• Nicotine e-cigarettes, counseling aid smoking cessation in randomized trial Scott Buzby
• VICTORIA: Vericiguat reduces events in high-risk HF Darlene Dobkowski, MA
• CARAVAGGIO
• iSmartHyp
• LINK HF
• MACHINE
• MAVERICK-HCM
• PRECOMBAT
• SPYRAL HTN-OFF MED
• VOYAGER-PAD